title: Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
authors: Department of Neuropsychiatry Fukushima Medical University School of Medicine Fukushima, Japan itaru@fmu.ac.jp Department of Neuropsychiatry Fukushima Medical University School of Medicine Fukushima, Japan Department of Neuropsychiatry Fukushima Medical University School of Medicine and Department of Neuropsychiatry Fukushima Medical University Aizu Medical Center Aizuwakamatsu, Fukushima, Japan Department of Neuropsychiatry Fukushima Medical University School of Medicine Fukushima, Japan.
authors: Itaru
authors: I
authors: Miura
authors: Keiko
authors: K
authors: Kanno-Nozaki
authors: Mizuki
authors: M
authors: Hino
authors: Sho
authors: S
authors: Horikoshi
authors: Takafumi
authors: T
authors: Ota
authors: Hirobumi
authors: H
authors: Mashiko
authors: Shin-Ichi
authors: S
authors: Niwa
authors: Hirooki
authors: H
authors: Yabe
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole / Q000627:therapeutic use*; D005260:Female; D006719:Homovanillic Acid / Q000097:blood*; D006801:Humans; D054643:INDEL Mutation / Q000235:genetics*; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000097:blood; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents; C581293:DRD2 protein, human; D017448:Receptors, Dopamine D2; D008734:Methoxyhydroxyphenylglycol; D000068180:Aripiprazole; D006719:Homovanillic Acid